CAO Pharmaceuticals
About this raise: CAO Pharmaceuticals is testing the waters on Silicon Prairie Online. The pharmaceutical company specializes in oral and non-toxic cancer treatment options using camptothecin (cpt). The company is testing a cpt derivative, CZ48, for toxicity and efficiency against cancers of the bladder, breast, kidney, lungs, ovary, pancreas, and prostate. Zhisong Cao founded CAO Pharmaceuticals in May 2015. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5,000,000. The campaign proceeds will be used for the Phase 2 FDA trial, trial expenses, laboratory rental, utilities, expenses, and pipeline medication development.
Investment Overview
Not Funded: $1,000
Deal Terms
Total Commitments ($USD)
- Platform
- Silicon Prairie Online
- Start Date
- 05/02/2022
- Close Date
- 04/24/2023
$10,000
$5,000,000
$1,000
Equity - Common
Pre-Seed
RegCF
$1.00
$1,000,000
Company & Team
Company
- Year Founded
- 2015
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $0
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/24/2023 | Silicon Prairie Online | $1,000,000 | $1,000 | Equity - Common | Not Funded | RegCF |